StonvexLoading…
StonvexStonvexStonvexCore line items from IDT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-07-31 | Annual 2024 2024-07-31 | Annual 2023 2023-07-31 | Annual 2022 2022-07-31 |
|---|---|---|---|---|
Revenue | $1.23B | $1.21B | $1.24B | $1.36B |
Operating Income | $100.42M | $64.75M | $60.74M | $60.09M |
Net Income | $76.09M | $64.45M | $40.49M | $27.03M |
EPS (Diluted) | $3.01 | $2.54 | $1.58 | $1.03 |
Total Assets | $626.20M | $550.10M | $510.81M | $497.09M |
Total Liabilities | $295.79M | $283.54M | $300.34M | $316.27M |
Cash & Equivalents | $226.50M | $164.56M | $103.64M | $98.35M |
Free Cash Flow OCF − CapEx | $106.29M | $59.27M | $30.45M | $7.53M |
Shares Outstanding | 25.30M | 25.40M | 25.58M | 26.36M |